NasdaqGM - Delayed Quote USD

TScan Therapeutics, Inc. (TCRX)

7.29 -0.09 (-1.22%)
At close: April 25 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
21,049.00
21,049.00
13,535.00
10,141.00
1,085.00
Operating Expense
114,507.00
114,507.00
80,171.00
58,782.00
27,318.00
Operating Income
-93,458.00
-93,458.00
-66,636.00
-48,641.00
-26,233.00
Net Non Operating Interest Income Expense
4,240.00
4,240.00
415.00
16.00
106.00
Pretax Income
-89,218.00
-89,218.00
-66,221.00
-48,625.00
-26,127.00
Net Income Common Stockholders
-89,218.00
-89,218.00
-66,221.00
-48,625.00
-26,127.00
Diluted NI Available to Com Stockholders
-89,218.00
-89,218.00
-66,221.00
-48,625.00
-26,127.00
Basic EPS
-1.36
--
-2.75
-4.17
-1.09
Diluted EPS
-1.36
--
-2.75
-4.17
-1.09
Basic Average Shares
65,599.86
--
24,048.27
11,662.67
23,938.37
Diluted Average Shares
65,599.86
--
24,048.27
11,662.67
23,938.37
Total Operating Income as Reported
-93,458.00
-93,458.00
-66,636.00
-48,641.00
-26,233.00
Total Expenses
114,507.00
114,507.00
80,171.00
58,782.00
27,318.00
Net Income from Continuing & Discontinued Operation
-89,218.00
-89,218.00
-66,221.00
-48,625.00
-26,127.00
Normalized Income
-89,218.00
-89,218.00
-66,221.00
-48,625.00
-26,127.00
Interest Income
7,999.00
7,999.00
1,591.00
16.00
106.00
Interest Expense
3,759.00
3,759.00
1,176.00
--
--
Net Interest Income
4,240.00
4,240.00
415.00
16.00
106.00
EBIT
-85,459.00
-85,459.00
-65,045.00
-48,625.00
-26,233.00
EBITDA
-80,098.00
-80,098.00
-59,908.00
-45,297.00
-25,003.00
Reconciled Depreciation
5,361.00
5,361.00
5,137.00
3,328.00
1,230.00
Net Income from Continuing Operation Net Minority Interest
-89,218.00
-89,218.00
-66,221.00
-48,625.00
-26,127.00
Normalized EBITDA
-80,098.00
-80,098.00
-59,908.00
-45,297.00
-25,003.00
12/31/2020 - 7/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYRE Spyre Therapeutics, Inc.
32.47
-1.58%
 
TRDA Entrada Therapeutics, Inc.
12.36
-0.56%
 
TYRA Tyra Biosciences, Inc.
15.11
-5.56%
 
EWTX Edgewise Therapeutics, Inc.
15.94
-1.06%
 
CGEM Cullinan Therapeutics, Inc.
19.25
+1.91%
 
CRGX CARGO Therapeutics, Inc.
18.28
-2.51%
 
SWTX SpringWorks Therapeutics, Inc.
44.20
+1.89%
 
STRO Sutro Biopharma, Inc.
3.4200
-1.44%
 
RPTX Repare Therapeutics Inc.
3.1500
-4.55%
 
PRLD Prelude Therapeutics Incorporated
4.0400
+4.39%